.png)
Author Notes
Authors’ addresses: Norman L. Beatty, Division of Infectious Diseases and Global Medicine, University of Florida College of Medicine, Gainesville, FL, E-mail: norman.beatty@medicine.ufl.edu. Colin J. Forsyth, Drugs for Neglected Diseases Initiative, New York, NY, E-mail: cforsyth@dndi.org. Robert H. Gilman, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, E-mail: gilmanbob@gmail.com. Davidson H. Hamer, Boston University Schools of Public Health and Medicine, Boston, MA, E-mail: dhamer@bu.edu. Andrés F. Henao-Martínez, Division of Infectious Diseases, University of Colorado, Anschutz Medical Campus, Aurora, CO, E-mail: andres.henaomartinez@cuanschutz.edu. Natasha Hochberg, Boston Medical Center, Boston, MA, and Boston University School of Medicine, Boston, MA, E-mail: nhoch@bu.edu. Jen Manne-Goehler, Division of Infectious Diseases, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, E-mail: jen.manne@gmail.com. Rachel Marcus, Latin American Society of Chagas, Bristow, VA, and Medstar Union Memorial and Good Samaritan Hospitals, Baltimore, MD, E-mail: doctorchagas@gmail.com. Sheba Meymandi, Michael R. Reich, Harvard T.H. Chan School of Public Health, Boston, MA, E-mail: michael_reich@harvard.edu. David Geffen School of Medicine at the University of California-Los Angeles, Los Angeles, CA, and Olive View-UCLA Medical Center, Los Angeles, CA, E-mail: smeymandi@dhs.lacounty.gov. Adrienne Showler, Division of Infectious Disease, Georgetown University Hospital, Washington, DC, E-mail: showler@gunet.georgetown.edu. Paula Stigler Granados, Division of Global Health and Environmental Health, School of Public Health, San Diego State University, San Diego, CA, E-mail: paula.stigler@gmail.com.